Loading

Original Research Open Access
Volume 4 | Issue 1

Decisional incentive sensitivity is linked to contingency management outcome and striatal dopamine signaling in individuals with cocaine use disorder: a preliminary study

  • 1Northwell, New Hyde Park, NY, USA
  • 2Departments of Psychiatry, Molecular Medicine and Psychology, Hofstra University, Hempstead, NY, USA
  • 3Institute of Behavioral Science, Feinstein Institutes for Medical Research, Manhasset, NY, USA
  • 4Department of Psychiatry, Columbia University Irving Medical Center, NY, USA
  • 5Neuroscience and Surgery Institute of Delaware, Newark, DE, USA
  • 6Lankenau Medical Center, Wynnewood, PA, USA
  • 7VA New Jersey Health Care System, East Orange, NJ, USA
  • 8Department of Pharmacology, Physiology & Neuroscience, Rutgers University-New Jersey Medical School, Newark, NJ, USA
  • 9Rutgers University – Newark, Newark, NJ, USA
+ Affiliations - Affiliations

*Corresponding Author

Nehal P. Vadhan, nvadhan@northwell.edu

Received Date: November 21, 2025

Accepted Date: February 16, 2026

Abstract

Background: Nontreatment-seeking individuals with cocaine use disorder (CUD) have been found to exhibit decision-making on laboratory tasks that is risky but also sensitive to monetary incentive, relative to controls. Objective: The purpose of this study was to replicate these findings in treatment-seeking individuals and explore their relationships with voucher-based treatment outcome and striatal dopamine (DA) release. Methods: This study was approved by the Institutional Review Board, and all participants provided written informed consent to participate. Eighteen briefly-abstinent individuals seeking treatment for CUD and 19 control participants were compared on performance of a modified Iowa Gambling task (mIGT) under both hypothetical and cash earning conditions. The CUD participants subsequently received Positron Emission Tomography (PET) scans with [11C]raclopride with methylphenidate (60 mg) challenge and then 12 weeks of Community Reinforcement Approach plus Vouchers (CRA+V) treatment. Results: On the mIGT, the CUD participants’ advantageous card selection was selectively more sensitive to the presence of a monetary incentive, relative to controls (F4,128 = 3.10, p<0.05). Among the male CUD participants, those who exhibited greater DA release in the ventral striatum (VSt), and those who responded to the CRA+V treatment, exhibited greater mIGT incentive sensitivity than those who were nonresponders (F4,44 = 5.84, p<0.01), and who exhibited relatively decreased VSt DA release (F4,48 = 2.55, p<0.05). Conclusions: Participants seeking treatment for CUD exhibited selectively increased decisional incentive sensitivity, relative to controls. For the male CUD participants, greater incentive sensitivity was associated with greater VSt DA release and better CRA+V outcome. These findings appear partially consistent with previous findings on cognition and motivation in individuals with CUD, and suggest a heuristic model connecting striatal DA, incentive sensitivity, and CRA+V outcome. 

Keywords

Cocaine, Iowa Gambling task, Decision-making, Contingencies, Reinforcement, Motivation community reinforcement, Dopamine, Striatum, PET

Introduction

Cocaine use remains prevalent in the US (>2 million current users; SAHMSA, 2022) and cocaine use disorder (CUD) (>1.4 million past-year cases; SAHMSA, 2022) has been difficult to treat. Community Reinforcement Approach plus Vouchers treatment [1] is a moderately efficacious approach that shapes cocaine abstinence with monetary rewards for initial abstinence and naturalistic rewards for sustained abstinence [2–4]. However, treatment response tends to be dichotomous and established early in treatment [5], suggesting that there is differential sensitivity to these alternative reinforcers. Investigating this sensitivity is critical to increasing treatment efficacy and broadening its effectiveness.

In terms of understanding such individual differences, psychological functions that lie at the intersection of cognition, motivation and reward have been shown to relate to the outcome of voucher-based treatment [6] for CUD [7–10]. Decision-making, defined briefly as the balancing of choices that bring larger but riskier rewards with those that bring smaller but safer ones [11], is a related candidate mechanism that has been minimally explored in this regard [12].

Individuals with CUD have been repeatedly found to be risky in their decision-making on laboratory tasks involving monetary earnings and losses [e.g., 13–16] and weak in underlying stimulus-response (S-R) learning functions [17–20], relative to non-cocaine users. However, the typical use of hypothetical money in most of these studies [21] raises questions of performance motivation and ecological validity.

We [15] found that while nontreatment-seeking individuals with CUD (n=25) made riskier decisions than controls (n=19) under hypothetical earnings/losses on a modified version of the Iowa Gambling Task (IGT; [22,23], there were no group differences when actual cash earnings/losses were employed. Similarly, in other groups of substance users, monetary incentives have been found to: 1) decrease risk-taking (Balloon Analogue Risk Task; [24,25], 2) increase response inhibition (anti-saccade task; [26] and improve (via contingency management; CM) adherence to and cognitive outcome from cognitive remediation [27]. Thus, incentives can improve cognitive performance, reduce aspects of impulsivity, and catalyze the learning of more adaptive choices. However, there may be individual variability in sensitivity to incentives that have relevance for outcome prediction.

Processing of monetary rewards has been directly and indirectly found to be related to dopamine (DA) transmission in the striatum [e.g., 28–32]. Importantly, DA deficiency in the ventral striatum (VSt) in CUD participants has been repeatedly found [33] and prospectively associated to: 1) increased cocaine self-administration in the human laboratory [34], and 2) decreased response to CRA+V therapy [34,35]; both procedures leverage financial incentive to challenge decisions to use cocaine.

Studies in treatment-seekers for methamphetamine (MA) use disorder demonstrated that CM nonresponders exhibited riskier IGT card selection relative to healthy controls and CM responders [36], and that more conservative card selection was prospectively associated with MA abstinence [37]. These findings explicitly link decision-making to voucher treatment outcome, but these studies did not employ a choice-contingent monetary incentive on the IGT, nor any neurobiological measure. This limits a more comprehensive understanding of potential mechanisms.

Thus, the objectives of the current study were to analyze data from a previous study [35] to: 1) replicate and extend several studies [i.e., 15–18] by evaluating mIGT performance (with and without monetary incentive) and S-R learning performance in abstinent individuals seeking treatment for CUD, and controls; and 2) derive measures of incentive sensitivity and determine their relationship to clinical and neurobiological variables in the CUD participants (i.e., CRA+V treatment outcome, VSt DA function). We hypothesized that: 1) individuals with CUD would exhibit greater incentive sensitivity on the mIGT and weaker S-R learning performance than controls; and 2) individuals with CUD with efficacious treatment response/greater VSt DA release would exhibit greater incentive sensitivity than those with non-efficacious treatment response/lesser DA release.

Materials and Methods

This study was approved by the Institutional Review Board of the New York State Psychiatric Institute and was carried out following the rules of the Declaration of Helsinki of 1975 [38]. All participants provided written informed consent and were compensated for their time. The submitted manuscript adheres to the ICMJE Recommendations [39]. All data were collected at Columbia University Irving Medical Center.

Participants

Participants were males and females between 21 and 45 years old. Participants were excluded if they met criteria for any DSM-IV Axis I disorder including other substance use disorders other than CUD (for the cocaine users), and if they reported current use of psychoactive medications, and substances other than cocaine, cannabis, alcohol, nicotine or caffeine. Illicit substance use and nonuse was verified by urine toxicology tests during screening and testing. This was a sample of convenience.

Individuals with cocaine use disorder (CUD)

These were a subset of participants seeking treatment for CUD from a previously published study [35] that received the cognitive assessment (n=18), neuroimaging (n=17) and CRA+V (n=18). Methods for participant recruitment, screening and neuroimaging are described in detail in that article and are presented briefly here.

Control participants

Nineteen individuals without cocaine use, who were independently recruited (i.e., a different control group than from the primary study) via local newspaper, internet and flier advertisements to match the presence of alcohol and cannabis use in the CUD participants, participated in this study. Reported lifetime use of cocaine greater than 10 times was exclusionary. All participants stated that they were not seeking or engaged in treatment for any substance use disorder. They completed their participation within one week of screening and were compensated for their time.

Demographic, clinical, and substance use characteristics for both groups are presented in Table 1. The CUD group was predominantly male and of late 30s mean age, with an early onset of regular cocaine use. Continuous variables were analyzed with two-tailed independent-samples t-tests and categorical variables were analyzed with chi-square.

Significant group differences were seen for depression and impulsivity symptoms (BDI-II; EIQ; CUD > Cont), proportion of female participants (Cont > CUD) and self-reported amount of cannabis use per occasion (Cont > CUD).

Table 1. Demographic and clinical characteristics.

 

Cocaine users (N=18)

Controls (N=19)

Test value

P value a

 

M

SD

M

SD

 

 

Age (yrs)

37.2

6.4

33

7.8

t(35) = -1.8

0.08

Education completed (yrs)

13.1

2.4

14.2

2.4

t(35) = 1.6

0.12

Annual household income

26,077

21,484

26,147

19,761

t(35) = 0.1

0.99

BDI-II total score

13.9

7.3

2.7

5

t(35) = -5.5

<0.001

RAB total score

4.12

2.89

3.94

1.83

t(33) = -0.2

0.83

BIS total score

68.13

9.56

71.43

8.33

t(28) = 1.0

0.33

 

N

%

N

%

   

Sex

   Male

   Female

 

15

3

 

83.3

16.7

 

8

11

 

42.1

57.9

 

Fisher’s exact = 0.02

Raced

   White

   Black

   Hispanic

   Other

 

8

4

4

2

 

44.4

22.2

22.2

11.1

 

7

9

2

1

 

36.8

47.4

10.5

5.3

 

χ2 (1) = 0.2

χ2 (1) = 2.6

 

0.64

0.11

Cocaine

   Age of onset of regular use (yrs)

   Frequency (days/past 30)

   Amount ($/occasion)

 

18.8

16.9

139.8

 

3.1

8.3

104.7

 

 

 

 

Alcohol

   Frequency (days/past 30)

   Amount (SDUs/occasion)

N=12

14.8

3.8

67%

11

1.8

N=17

8.8

2.8

90%

3.8

1.5

 

t(12.9) = -1.8

t(27) = -1.8

 

0.09

0.09

Cannabis

   Frequency (days/past 30)

   Amount ($/occasion)

N=9

6.2

0.8

50%

7.5

0.3

N=12

12.9

7

63%

8.3

2.6

 

t(19) = 1.9

t(11.5) = 7.0

 

0.07

<0.001

a bold indicates overall group difference (p<0.05); d comparisons based on Black vs. not Black and White vs. not White

 

Design and procedure

Monitoring of cocaine abstinence

Two weeks of verified abstinence were required of the individuals with CUD prior to neuroimaging [35]; they had the option of either staying inpatient at CUMC’s Irving Research Unit (n=11) or submit to thrice-weekly outpatient urine toxicology testing (n=7). Controls’ lack of current cocaine use was verified via urine toxicology testing during screening and testing sessions.

Cognitive testing session

All testing took place in a quiet room (1 day prior to imaging for CUD participants); participants were given in-person instructions per task and then monitored by remote video; outpatient participants were instructed not to use any psychoactive substance on the morning of testing except regular caffeine and nicotine. All participants passed alcohol breathalyzer, field sobriety tests, spent 20–30 min completing self-report/urine tests, and displayed no behavioral signs of intoxication as noted by the experimenter; thus participant intoxication was unlikely.

Measures (all computerized, and described briefly here)

Decision-making and incentive sensitivity

Modified Iowa Gambling Task [23]: The mIGT task was administered under two conditions (100 trials each) to each participant: (1) hypothetical payment (Hypothetical) and (2) cash payment (Cash). Condition order was counterbalanced with an interval of 2–3 hours, and participants were blind to the repeated administration and condition type until just prior to condition onset.

Four decks of cards (A–D) were displayed and participants were credited with $10. Participants were instructed to select cards (one at a time) from any of the decks to win as much money as possible, and that some decks were better than others. Following each card selection, participants were credited with some amount of money; occasionally after a card selection, participants simultaneously won and lost some amount of money. Participants were informed that they would keep any winnings. Two of the decks (C and D) paid an average of $0.50 per card selection but were associated with an average loss of $0.25 per selection (potential net earnings=$25.00). In contrast, the other two decks (A and B) paid an average of $1.00 per selection but were associated with an average penalty of $1.25 per card (potential net loss=$25.00). These values were proportionally identical to the traditional IGT, and deck location was randomly assigned each administration. The 3 primary performance measures were: 1) card selection (number of cards selected from advantageous decks), money earned ($), and time to complete the task (sec).

Stimulus-Response Learning

Weather Prediction Task [40]: This task measures probabilistic category learning via binary choice. Participants were instructed to predict, via keystroke, the weather (“sun” or “rain”) based on a random array of 1–3 cards (200 trials) and were given accuracy feedback. Each card was associated with each outcome with a fixed probability (e.g., card 1 was associated with sun on 80% of the trials on which it appeared and with rain on 20% of the trials on which it appeared) and the outcomes sun and rain appeared equally often [40]. The dependent measure was percent optimal responding, i.e., choosing the outcome that was most associated with each particular stimulus configuration over the course of the task (see [41]).

Acquired Equivalence Task [42]: This task measures equivalence learning and learning transfer via binary choice. On each trial, 1 of 4 distinct cartoon faces were displayed (antecedents A1, A2, B1, or B2) and 2 of 4 distinct cartoon fish (consequents X1, X2, Y1, or Y2). The participant decided which fish belonged to the person (at first by guessing) with a key response and received accuracy feedback. In Acquisition stage 1 (shaping), two antecedents were each associated with a different consequent (e.g., A1àX1, B1àY1); in Acquisition stage 2 (equivalence training) the remaining two antecedents were each associated with a stage 1 consequent (A2àX1, B2àY1). Acquisition stage 3 (novel consequents) consisted of two antecedents trained with novel consequents (A1àX2, B1àY2). During the Transfer phase, participants were tested (with no feedback) on all six previously-trained face-fish pairs as well as two novel (untrained) pairs (A2àX2, B2àY2). The dependent measure for Acquisition stages 1–3 was errors to criterion, and the dependent measures for the Transfer phase was the percent of total errors made on trials that tested novel and previously-learned pairs.

Naturalistic behavior

Risk Assessment Battery (43): This is a 24-item questionnaire that measures drug and sexual risk-taking. The total score was employed in this study.

Barratt Impulsiveness Scale (44): This 30-item questionnaire measures attentional, motor, and non-planning features of impulsiveness. The total score was employed in this study.

Neuroimaging

See Martinez, Carpenter [35] for full details. For all subjects, [11C]raclopride was administered as a bolus and the PET scans were acquired on the ECAT EXACT HR+ scanner (Siemens/CTI, Knoxville, Tenn.) in three-dimensional mode over 60 minutes. All participants underwent two scans with [11C]raclopride: at baseline and following administration of oral methylphenidate (60 mg). A plasma sample for analysis of methylphenidate level was obtained just before the second scan. The PET data were analyzed by means of simplified tissue reference modeling [45], with the cerebellum used as a reference region to estimate nonspecific binding. The PET outcome measure was binding potential (BPND) defined as BPND = fND * Bmax/KD (see Supplementary File) [46]. The percent change in [11C]raclopride binding following methylphenidate administration was defined as (BPNDbaseline – BPNDmethylphenidate)/BPNDbaseline [47,48], with greater values indicating greater DA release. In addition to the PET scans, each participant also underwent a magnetic resonance imaging (MRI) scan (GE Signa EXCITE 3T/94 cm scanner, GE Medical Systems, Milwaukee, Wis.) for identification of the region of interest (ventral striatum).

Treatment

Following the PET scans, the cocaine-dependent subjects began manualized Community Reinforcement Approach plus Vouchers (CRA+V; (1); see Supplement for details). The therapy sessions were conducted twice weekly by trained therapists, with weekly supervision provided. The participants received voucher points for each urine sample that tested negative for a cocaine metabolite (i.e., benzoylecgonine). The voucher points ($0.25) were acquired on an escalating schedule that started at 10 points for the first cocaine-free sample, and each subsequent cocaine-free sample increased the voucher value by 5 points. Participants also received a bonus of 40 points ($10.00) for every three consecutive cocaine-free urine samples (equivalent to a week of abstinence). Participants could earn a maximum of $997.50 in vouchers for submitting cocaine-free urine samples at 100% of the scheduled treatment visits (36 over the course of 12 weeks).

Data analyses

General approach

Performance on the three tasks was first examined as a function of group (individuals with CUD vs. controls) and trial block/type with mixed-design repeated measures Analysis of Variance (ANOVA); one ANOVA was conducted for each dependent measure. To examine the effects of sex (female vs male) on performance [49], sex was added as an additional independent factor to the above models. Significant interactions were probed with simple effect tests. Interactions involving both group and sex were not reported or probed due to the relatively small sample of females (n=3) in the cocaine-using group. For all analyses, only p-values <0.05 were considered statistically significant and Huynh-Feldt corrections were employed to correct for violations of sphericity.

See Supplementary File for task-specific data analysis characteristics.

Incentive sensitivity

Incentive sensitivity indices were derived by calculating the difference score between mIGT performance under the cash condition and performance under the hypothetical condition; larger scores indicated relatively better performance under the actual cash incentive (i.e., greater adaptive incentive sensitivity).

CUD-only analyses

Due to the relatively small sample size, the relationships of task variables to treatment response and to dopamine release were examined separately. To account for the potential influence of sex differences on task performance, these secondary set of analyses were performed only on the male participants’ data (n=15).

Treatment response

The distribution of total CRA+V vouchers earned for the male subsample was examined to determine treatment response classification. As in [35], the distribution was bimodal (5 responders/10 nonresponders). Comparison on total voucher earnings between responders and nonresponders via univariate ANOVAs was conducted to verify subgroup assignment. The hypothesized relationships between incentive sensitivity and treatment outcome were examined by comparing these treatment subgroups on the cognitive tasks, with mixed-design repeated measures Analyses of Variance (ANOVA). Due to potential subgroup differences in cocaine use, and corresponding influences on treatment outcome, baseline frequency of cocaine use (days in the past 30) was added as a covariate.

Dopamine function

The distribution of striatal dopamine release for the male participants was examined to determine subgroups based on dopamine release capacity (high versus low). The distributions were bimodal (8 high/6 low). Comparison on total voucher earnings between responders and nonresponders via univariate ANOVAs was conducted to verify subgroup assignments. The hypothesized relationships between incentive sensitivity and DA release capacity were examined by comparing these DA release capacity subgroups on the mIGT indices, with mixed-design repeated measures Analyses of Variance (ANOVA).

To address potential asymmetric effects of condition order (Hypothetical first vs. Cash first) on performance, it was included as a covariate in all analyses involving the mIGT.

Results

Statistical results are presented inline in the text for figures, and in Supplementary Tables 2–7 for other data.

CUD and control participants

mIGT performance

Card selection (Figure 1): There were no main effects of monetary condition (F1,32 = 1.83, ηp2 = 0.05, p>0.05), block (F4,128 = 0.63, ηp2 = 0.02, p>0.05), or sex (F1,32 = 2.94, ηp2 = 0.08, p>0.05), but there was a main effect of group (F1,32 = 5.66, ηp2 = 0.15, p<0.05), with the CUD participants selecting more cards from advantageous decks on average per block than the control participants. However, there were block × group (F4,128 = 2.53, ηp2 = 0.07, p<0.05), monetary condition × block × group (F4,128 = 3.10, ηp2 = 0.09, p<0.05) and monetary condition × block × sex (F4,128 = 3.03, ηp2 = 0.09, p<0.05) interactions.

The CUD participants’ card selection was more advantageous overall than the controls’ (Panel A) for blocks 2 (p<0.01) and 5 (p<0.05), with no group differences for any of the other blocks (p>0.05). For the CUD participants, card selection was more advantageous under the cash than hypothetical condition for block 2 (p<0.05), whereas there was no such difference for any block for the controls (p>0.05). Thus, the CUD participants selected more advantageously: 1) specifically for 2 blocks, relative to the control participants, and 2) under the cash contingency relative to the hypothetical contingency (for 1 of those trial blocks).

For the females (Panel B), card selection was more advantageous under the cash than hypothetical condition for block 2 (p<0.05), whereas there was no such difference for any block for the males (p>0.05). For both group comparisons, in no case was card selection significantly more advantageous under the hypothetical than cash condition (p>0.05).

mIGT Money earned (Supplementary Table 2A): There were no main effects of monetary condition, block, group or sex (p>0.05). There was a block × group interaction (p<0.05), whereby the controls earned more money on the first block (p<0.05).

mIGT Task completion time (Supplementary Table 2B): There was a main effect of monetary condition on completion time, with slower performance for both groups under the Cash condition, relative to the Hypothetical condition (p<0.001). There were no main effects of block, group or sex (p>0.05), and no other interactions (p>0.05).

Weather Prediction task (Supplementary Table 3A)

There was a main effect of block (p<0.01), with participants making more optimal responses as the task progressed (4, 3, 2 > 1; p<0.05), but no main effects of group or sex (p>0.05). However, there was a block × group interaction (p<0.05), with the controls exhibiting better optimal responding on blocks 2 and 4 than the CUD participants (p<0.05). Thus, the CUD participants exhibited weaker learning rates than the controls, with no differences between males and females.

Acquired Equivalence task (Supplementary Table 3B)

On the Acquisition phase, there were no main effects of block, group or sex (p>0.05), and no interactions (p>0.05). On the Transfer phase, there was a main effect of trial type (p<0.05), with participants making a greater percentage of errors on the new (Transfer phase) discriminations than the old (Acquisition stage 1) discriminations. There were no main effects of group or sex, or interactions (p>0.05). Thus, there was equivalent learning and transfer between groups.

Incentive sensitivity, treatment response and dopamine release in CUD

CUD Subgroup verification (males only; Supplementary Table 4): There were significant effects (p<0.05) of: 1) treatment subgroup on vouchers earned (A), and 2) DA release subgroup on DA release (B). The treatment responders earned more vouchers than the nonresponders and the DA high group exhibited greater DA release than the low group. Thus, subgroup assignments were verified.

mIGT Incentive sensitivity (males only): There were no main effects of block or treatment subgroup, nor a block × subgroup interaction (p>0.05) on the GT card selection difference score, and these patterns of significance did not change following covariation for baseline cocaine use (p>0.05; Supplementary Table 5A). For DA release (Supplementary Table 6A), there was a main effect (F4,44 = 5.27, ηp2 = 0.32, p<0.01) of block (1>2-5, 2>3; p<0.05). There was no main effect of DA subgroup (p>0.05), but there was a block × subgroup interaction (F4,44 = 5.84, ηp2 = 0.35, p<0.01), with the DA high group exhibiting a greater score at block 3 than the DA low group (Figure 2A; p<0.01).

There were no main effects of block (F4,48 = 0.35, ηp2 = 0.03, p>0.05) or treatment subgroup (F1,12 = 1.50, ηp2 = 0.101 p>0.05), and the block × subgroup interaction was marginal (F4,48 = 2.55, ηp2 = 0.18, p=0.05), on the GT money earned difference score. Following covariation for baseline cocaine use, the pattern of significance for main effects remained the same (p>0.05; Supplementary Table 5B). However, the block × subgroup interaction reached significance, with the responders exhibiting a greater difference score at block 4 than the nonresponders (Figure 2b; p<0.01), and vice-versa for block 3 (p<0.05). There was no main effect of block or DA release subgroup, and there was no block × subgroup interaction on the GT money earned difference score (p>0.05; Supplementary Tables 5B and 6B). There was no main effect (p>0.05) of treatment subgroup or DA release subgroup (Supplementary Table 6C) on the GT completion time difference score, and this did not change for treatment subgroup following covariation for baseline cocaine use (Supplementary Table 5C).

Thus, for the male CUD participants, the sensitivity of card selection to monetary incentive was selectively greater (i.e., for one mIGT block) for the high DA releasers than the low releasers. The sensitivity of money earned to monetary incentive was selectively greater for the treatment responders (on one mIGT block), and for the nonresponders (on a different block), once baseline cocaine use was accounted for.

Discussion

The primary results of this study indicated that: 1) advantageous card selection on the Modified Iowa Gambling Task (mIGT) was increased, but also selectively more sensitive to a real monetary incentive (i.e., decisional incentive sensitivity), in adult participants beginning community reinforcement approach plus vouchers (CRA+V) therapy for cocaine use disorder (CUD), than control participants. 2) Probabilistic category learning (Weather Prediction task) was decreased for CUD participants, relative to controls. 3) Among the male CUD participants, the magnitude of mIGT incentive sensitivity was greater in those who subsequently exhibited relatively greater striatal dopamine release capacity, and (selectively) for those who subsequently responded efficaciously to an incentive-based treatment, relative to those who had relatively lesser dopamine release capacity or were treatment nonresponders.

The finding of increased advantageous card selection on the mIGT overall for these treatment-seeking CUD participants relative to controls was the opposite result of our previous study in nontreatment-seeking CUD participants [15]. It may be driven in part by the disproportionate positive effect of the monetary incentive on the 2nd trial block for the CUD participants (trial block functions were not examined in the previous study). Additionally, the monetary incentive did not improve card selection for any block for the controls. These findings, combined with increased task completion time (i.e., effort incentive sensitivity) overall, are partially consistent with our previous study [15]. The results may suggest that while a monetary incentive may promote greater deliberation and effort on the task in general, it preferentially improves the decision-making of CUD participants (see [50]).

Although the relevance of the specific task block that was affected is unclear, the finding of another (seemingly unrelated) group difference on mIGT card selection at the same block – that female participants were more sensitive to the monetary incentive than the male participants – may suggest that incentives impact card selection only after some initial experience with the task. Regardless, this indicates that sex differences need to be taken into account in studies of decision-making and incentive sensitivity [51].

The finding of decreased probabilistic category learning performance in CUD participants is consistent with previous studies [18,19], but the effects of a monetary contingency on performance of these and other S-R learning tasks by CUD participants (e.g., [20]) have not been studied.

The previously published primary paper [35] from this study showed that in the full sample of CUD participants (males and females), DA release capacity in the ventral striatum (VSt) was greater in subsequent CRA+V responders than non-responders. Additional predictors of outcome from this same sample include clinic attendance early in treatment [52] and implicit beliefs in the positive effects of cocaine (inverse association) [7]. Here, we show in a male subsample that the magnitude of mIGT decision incentive sensitivity was positively associated with VSt DA release capacity, and (to a lesser degree) mIGT outcome incentive sensitivity was associated with CRA+V response; novel findings to our knowledge. This suggests that incentive sensitivity, as derived from the difference between performance under hypothetical and cash incentives on a decision-making task, is a potential cognitive-motivational mechanism by which increased striatal DA function leads to CRA+V outcome success in CUD participants. This adds to the existing literature relating decisional biases to voucher treatment outcome for stimulant use disorder [36,37], and if replicated, may suggest a clinical utility for measuring decisional incentive sensitivity at treatment baseline to aid in intervention choices.

These results converge with findings that neural activation (as measured by fMRI) in multiple brain areas, including the ventral striatum (VSt), in response to partially choice-contingent cash reward anticipation and receipt (Monetary Incentive Delayed Task; Knutson, Westdorp [53)] was elevated in CUD individuals relative to controls [54]. Interestingly, in that study, neural activation in the bilateral thalamus and right caudate, but not VSt, was prospectively associated with percent cocaine-negative urine toxicology in mixed treatment (only 4/22 participants received voucher-based clinical interventions). The caudate is known to be important for S-R learning [55,56], and in an exploratory fashion we found that S-R learning performance, including learning transfer, was associated with post-voucher clinical outcome (Supplementary Figures 2 and 3).

This is interesting since the ability to transfer learning to novel contexts is, arguably, what success in the post-voucher phase of CRA+V depends on. Similarly, the thalamus is important for learning-based attentional function [57], and we previously found that attentional bias towards cocaine-related stimuli was similarly associated with outcome in this same phase of treatment [7]. Thus, distinct brain regions within a network and their corresponding cognitive-motivational functions differentially map on to treatment outcome phases depending on the nature of task and treatment incentives.

It should be noted that despite our primary findings, for some participants the presence of a monetary incentive was associated with decreased advantageous decision-making, similar to real-life high-risk wagering. In the current study (Supplementary Table 7, Supplementary Figure 3), participants whose mIGT performance decreased under the cash condition endorsed greater risk-taking impulsivity in the natural environment on questionnaire measures than those whose performance improved. This provides convergent evidence that task-measured incentive sensitivity is an ecologically-relevant and bi-directional construct that may help understand failure in CRA+V therapy.

There are several limitations to the current study. The small sample size did not permit more advanced statistics that may have addressed all the research questions more parsimoniously. Group differences in sex distribution and depression scores may have influenced the group cross-sectional findings and prevented inclusion of females in the CUD-only analyses. Finally, the $10 credit system for the Cash mIGT condition meant that task losses were not likely to be as salient as winnings.

Conclusion 

Participants seeking treatment for CUD exhibited selectively increased decisional incentive sensitivity, relative to controls, and for male CUD participants, greater incentive sensitivity was associated with greater VSt DA release and better CRA+V outcome. These preliminary data provide a potential model that links DA function, decisional incentive sensitivity and CRA+V outcome that should be explored further in future studies.

Conflict of Interest 

All authors declare that they have no relevant conflicts of interest.

Funding Statement

Funding for this study was provided by NIDA grants 020855, 008105 and 019933, by Columbia University's CTSA grant UL1 RR024156 from NCATS-NCRR/NIH and a Columbia University Irving Scholars Award (NPV); these funding sources had no further role in study design; in the collection, analysis and interpretation of data; in the writing of the report; or in the decision to submit the paper for publication. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.

Acknowledgements

We gratefully acknowledge the assistance of Krysten Bold, Eliezer Pickholtz, and Olivia Wu, for assistance with participant screening, data collection, and entry, and Danusha Selva Kumar and Tanya Lalwani for additional data entry. We also thank the Irving Institute for Clinical and Translational Research (IICTR) of Columbia University Medical Center.

Portions of this research were presented at the 2018 annual meeting of the Society for Biological Psychiatry [58] and the 2020 Contingency Management Working Group of the College on Problems of Drug Dependence [59].

References

1. Budney AJ. A community reinforcement plus vouchers approach: Treating cocaine addiction. US Department of Health and Human Services, National Institutes of Health, National Institute on Drug Abuse; 1998.

2. Roozen HG, Boulogne JJ, van Tulder MW, van den Brink W, De Jong CA, Kerkhof AJ. A systematic review of the effectiveness of the community reinforcement approach in alcohol, cocaine and opioid addiction. Drug Alcohol Depend. 2004 Apr 9;74(1):1–13.

3. Schierenberg A, van Amsterdam J, van den Brink W, Goudriaan AE. Efficacy of contingency management for cocaine dependence treatment: a review of the evidence. Curr Drug Abuse Rev. 2012 Dec;5(4):320–31.

4. Oluwoye O, Kriegel L, Alcover KC, McPherson S, McDonell MG, Roll JM. The dissemination and implementation of contingency management for substance use disorders: A systematic review. Psychol Addict Behav. 2020 Feb;34(1):99–110.

5. Stitzer ML, Petry N, Peirce J, Kirby K, Killeen T, Roll J, et al. Effectiveness of abstinence-based incentives: interaction with intake stimulant test results. J Consult Clin Psychol. 2007 Oct;75(5):805–11.

6. Regier PS, Redish AD. Contingency Management and Deliberative Decision-Making Processes. Front Psychiatry. 2015 Jun 1;6:76.

7. Carpenter KM, Martinez D, Vadhan NP, Barnes-Holmes D, Nunes EV. Measures of attentional bias and relational responding are associated with behavioral treatment outcome for cocaine dependence. Am J Drug Alcohol Abuse. 2012 Mar;38(2):146–54.

8. Bickel WK, Jones BA, Landes RD, Christensen DR, Jackson L, Mancino M. Hypothetical intertemporal choice and real economic behavior: delay discounting predicts voucher redemptions during contingency-management procedures. Exp Clin Psychopharmacol. 2010 Dec;18(6):546–52.

9. Washio Y, Higgins ST, Heil SH, McKerchar TL, Badger GJ, Skelly JM, et al. Delay discounting is associated with treatment response among cocaine-dependent outpatients. Exp Clin Psychopharmacol. 2011 Jun;19(3):243–8.

10. Wardle MC, Vincent JN, Suchting R, Green CE, Lane SD, Schmitz JM. Anhedonia Is Associated with Poorer Outcomes in Contingency Management for Cocaine Use Disorder. J Subst Abuse Treat. 2017 Jan;72:32–9.

11. Bechara A. Risky business: emotion, decision-making, and addiction. J Gambl Stud. 2003 Spring;19(1):23–51.

12. Stoops WW, Kearns DN. Decision-making in addiction: Current knowledge, clinical implications and future directions. Pharmacol Biochem Behav. 2018 Jan;164:1–3.

13. Hulka LM, Eisenegger C, Preller KH, Vonmoos M, Jenni D, Bendrick K, et al. Altered social and non-social decision-making in recreational and dependent cocaine users. Psychol Med. 2014 Apr;44(5):1015–28.

14. Hulka LM, Vonmoos M, Preller KH, Baumgartner MR, Seifritz E, Gamma A, et al. Changes in cocaine consumption are associated with fluctuations in self-reported impulsivity and gambling decision-making. Psychol Med. 2015 Oct;45(14):3097–110.

15. Vadhan NP, Hart CL, Haney M, van Gorp WG, Foltin RW. Decision-making in long-term cocaine users: Effects of a cash monetary contingency on Gambling task performance. Drug Alcohol Depend. 2009 Jun 1;102(1-3):95–101.

16. Bornovalova MA, Daughters SB, Hernandez GD, Richards JB, Lejuez CW. Differences in impulsivity and risk-taking propensity between primary users of crack cocaine and primary users of heroin in a residential substance-use program. Exp Clin Psychopharmacol. 2005 Nov;13(4):311–8.

17. Vadhan NP, Myers CE, Rubin E, Shohamy D, Foltin RW, Gluck MA. Stimulus-response learning in long-term cocaine users: acquired equivalence and probabilistic category learning. Drug Alcohol Depend. 2008 Jan 11;93(1-2):155–62.

18. Vadhan NP, Myers CE, Benedict E, Rubin E, Foltin RW, Gluck MA. A decrement in probabilistic category learning in cocaine users after controlling for marijuana and alcohol use. Exp Clin Psychopharmacol. 2014 Feb;22(1):65–74.

19. Kumar DS, Benedict E, Wu O, Rubin E, Gluck MA, Foltin RW, et al. Learning functions in short-term cocaine users. Addict Behav Rep. 2019 Feb 8;9:100169.

20. Strickland JC, Bolin BL, Lile JA, Rush CR, Stoops WW. Differential sensitivity to learning from positive and negative outcomes in cocaine users. Drug Alcohol Depend. 2016 Sep 1;166:61–8.

21. Koffarnus MN, Kaplan BA. Clinical models of decision making in addiction. Pharmacol Biochem Behav. 2018 Jan;164:71–83.

22. Bechara A, Dolan S, Denburg N, Hindes A, Anderson SW, Nathan PE. Decision-making deficits, linked to a dysfunctional ventromedial prefrontal cortex, revealed in alcohol and stimulant abusers. Neuropsychologia. 2001;39(4):376–89.

23. Vadhan NP, Hart CL, van Gorp WG, Gunderson EW, Haney M, Foltin RW. Acute effects of smoked marijuana on decision making, as assessed by a modified gambling task, in experienced marijuana users. J Clin Exp Neuropsychol. 2007 May;29(4):357–64.

24. Lejuez CW, Aklin WM, Jones HA, Richards JB, Strong DR, Kahler CW, et al. The Balloon Analogue Risk Task (BART) differentiates smokers and nonsmokers. Exp Clin Psychopharmacol. 2003 Feb;11(1):26–33.

25. Bornovalova MA, Cashman-Rolls A, O'Donnell JM, Ettinger K, Richards JB, deWit H, et al. Risk taking differences on a behavioral task as a function of potential reward/loss magnitude and individual differences in impulsivity and sensation seeking. Pharmacol Biochem Behav. 2009 Sep;93(3):258–62.

26. Chung T, Geier C, Luna B, Pajtek S, Terwilliger R, Thatcher D, et al. Enhancing response inhibition by incentive: comparison of adolescents with and without substance use disorder. Drug Alcohol Depend. 2011 May 1;115(1-2):43–50.

27. Kiluk BD, Buck MB, Devore KA, Babuscio TA, Nich C, Carroll KM. Performance-Based Contingency Management in Cognitive Remediation Training: A Pilot Study. J Subst Abuse Treat. 2017 Jan;72:80–8.

28. Tom SM, Fox CR, Trepel C, Poldrack RA. The neural basis of loss aversion in decision-making under risk. Science. 2007 Jan 26;315(5811):515–8.

29. Tomer R, Slagter HA, Christian BT, Fox AS, King CR, Murali D, et al. Love to win or hate to lose? Asymmetry of dopamine D2 receptor binding predicts sensitivity to reward versus punishment. Journal of cognitive neuroscience. 2014 May 1;26(5):1039–48.

30. Guttman Z, Moeller SJ, London ED. Neural underpinnings of maladaptive decision-making in addictions. Pharmacol Biochem Behav. 2018 Jan;164:84–98.

31. Buckholtz JW, Treadway MT, Cowan RL, Woodward ND, Benning SD, Li R, et al. Mesolimbic dopamine reward system hypersensitivity in individuals with psychopathic traits. Nat Neurosci. 2010 Apr;13(4):419–21.

32. Schott BH, Minuzzi L, Krebs RM, Elmenhorst D, Lang M, Winz OH, et al. Mesolimbic functional magnetic resonance imaging activations during reward anticipation correlate with reward-related ventral striatal dopamine release. J Neurosci. 2008 Dec 24;28(52):14311–9.

33. Volkow ND, Fowler JS, Wang GJ, Baler R, Telang F. Imaging dopamine's role in drug abuse and addiction. Neuropharmacology. 2009;56 Suppl 1(Suppl 1):3–8.

34. Martinez D, Narendran R, Foltin RW, Slifstein M, Hwang DR, Broft A, et al. Amphetamine-induced dopamine release: markedly blunted in cocaine dependence and predictive of the choice to self-administer cocaine. Am J Psychiatry. 2007 Apr;164(4):622–9.

35. Martinez D, Carpenter KM, Liu F, Slifstein M, Broft A, Friedman AC, et al. Imaging dopamine transmission in cocaine dependence: link between neurochemistry and response to treatment. Am J Psychiatry. 2011 Jun;168(6):634–41.

36. Lake MT, Shoptaw S, Ipser JC, Takada S, van Nunen LJ, Lipinska G, et al. Decision-Making by Patients With Methamphetamine Use Disorder Receiving Contingency Management Treatment: Magnitude and Frequency Effects. Front Psychiatry. 2020 Feb 18;11:22.

37. Lake MT, Krishnamurti T, Murtaugh KL, van Nunen LJ, Stein DJ, Shoptaw S. Decision-making tendencies and voucher spending independently support abstinence within contingency management for methamphetamine use disorder. Exp Clin Psychopharmacol. 2023 Apr;31(2):324–9.

38. World Medical Association. World Medical Association Declaration of Helsinki: Ethical Principles for Medical Research Involving Human Participants. JAMA. 2025 Jan 7;333(1):71–4.

39. Editors ICoMJ. Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals 2025 [Available from: https://www.icmje.org/.

40. Gluck MA, Shohamy D, Myers C. How do people solve the "weather prediction" task?: individual variability in strategies for probabilistic category learning. Learn Mem. 2002 Nov-Dec;9(6):408–18.

41. Shohamy D, Myers CE, Onlaor S, Gluck MA. Role of the basal ganglia in category learning: how do patients with Parkinson's disease learn? Behav Neurosci. 2004 Aug;118(4):676–86.

42. Myers CE, Shohamy D, Gluck MA, Grossman S, Kluger A, Ferris S, ET AL. Dissociating hippocampal versus basal ganglia contributions to learning and transfer. J Cogn Neurosci. 2003 Feb 15;15(2):185–93.

43. Navaline HA, Snider EC, Petro CJ, Tobin D, Metzger D, Alterman AI, ET AL. Preparations for AIDS vaccine trials. An automated version of the Risk Assessment Battery (RAB): enhancing the assessment of risk behaviors. AIDS Res Hum Retroviruses. 1994;10 Suppl 2:S281–3.

44. Patton JH, Stanford MS, Barratt ES. Factor structure of the Barratt impulsiveness scale. J Clin Psychol. 1995 Nov;51(6):768–74.

45. Lammertsma AA, Hume SP. Simplified reference tissue model for PET receptor studies. Neuroimage. 1996 Dec;4(3 Pt 1):153–8.

46. Slifstein M, Laruelle M. Models and methods for derivation of in vivo neuroreceptor parameters with PET and SPECT reversible radiotracers. Nucl Med Biol. 2001 Jul;28(5):595–608.

47. Volkow ND, Wang GJ, Fowler JS, Logan J, Gatley SJ, Hitzemann R, et al. Decreased striatal dopaminergic responsiveness in detoxified cocaine-dependent subjects. Nature. 1997 Apr 24;386(6627):830–3.

48. Martinez D, Narendran R, Foltin RW, Slifstein M, Hwang DR, Broft A, et al. Amphetamine-induced dopamine release: markedly blunted in cocaine dependence and predictive of the choice to self-administer cocaine. Am J Psychiatry. 2007 Apr;164(4):622–9.

49. Wittwer A, Hulka LM, Heinimann HR, Vonmoos M, Quednow BB. Risky Decisions in a Lottery Task Are Associated with an Increase of Cocaine Use. Front Psychol. 2016 May 9;7:640.

50. Luijten M, Schellekens AF, Kühn S, Machielse MW, Sescousse G. Disruption of Reward Processing in Addiction : An Image-Based Meta-analysis of Functional Magnetic Resonance Imaging Studies. JAMA Psychiatry. 2017 Apr 1;74(4):387–98.

51. Lynch WJ. Modeling the development of drug addiction in male and female animals. Pharmacol Biochem Behav. 2018 Jan;164:50–61.

52. Luo SX, Martinez D, Carpenter KM, Slifstein M, Nunes EV. Multimodal predictive modeling of individual treatment outcome in cocaine dependence with combined neuroimaging and behavioral predictors. Drug Alcohol Depend. 2014 Oct 1;143:29–35.

53. Knutson B, Westdorp A, Kaiser E, Hommer D. FMRI visualization of brain activity during a monetary incentive delay task. Neuroimage. 2000 Jul;12(1):20–7.

54. Jia Z, Worhunsky PD, Carroll KM, Rounsaville BJ, Stevens MC, Pearlson GD, et al. An initial study of neural responses to monetary incentives as related to treatment outcome in cocaine dependence. Biol Psychiatry. 2011 Sep 15;70(6):553–60.

55. Poldrack RA, Clark J, Paré-Blagoev EJ, Shohamy D, Creso Moyano J, Myers C, et al. Interactive memory systems in the human brain. Nature. 2001 Nov 29;414(6863):546–50.

56. Packard MG, McGaugh JL. Double dissociation of fornix and caudate nucleus lesions on acquisition of two water maze tasks: further evidence for multiple memory systems. Behav Neurosci. 1992 Jun;106(3):439–46.

57. de Bourbon-Teles J, Bentley P, Koshino S, Shah K, Dutta A, Malhotra P, et al. Thalamic control of human attention driven by memory and learning. Curr Biol. 2014 May 5;24(9):993–9.

58. Vadhan N, Benedict E, Rubin E, Carpenter K, Nunes E, Martinez D. S270. Effort Sensitivity to Monetary Incentive on a Decision-Making Task is Associated With Striatal Dopamine Signaling and Contingency Management Outcome in Cocaine Users. Biological Psychiatry. 2018 May 1;83(9):S453.

59. Vadhan NP, Carpenter KM, Benedict EM, Myers CE, Gluck MA, Nunes EV, et al. Learning and incentive sensitivity in cocaine users: Links to contingency management outcome and striatal dopamine signaling. Contingency Management Working Group, College on Problems of Drug Dependence; Virtual2020.

Author Information X